Novel motif:45: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:44, 9 September 2013
name: | motif45_GCTCNGG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0043503 | skeletal muscle fiber adaptation | 3.800215e-11 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.228535e-10 |
GO:0032863 | activation of Rac GTPase activity | 8.395160e-10 |
GO:0050432 | catecholamine secretion | 9.167752e-10 |
GO:0000072 | M phase specific microtubule process | 1.991728e-9 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 3.252148e-9 |
GO:0010624 | regulation of Schwann cell proliferation | 4.301568e-9 |
GO:0032862 | activation of Rho GTPase activity | 1.614074e-8 |
GO:0035873 | lactate transmembrane transport | 1.716047e-8 |
GO:0048241 | epinephrine transport | 2.217435e-8 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 4.128903e-8 |
GO:0007386 | compartment pattern specification | 4.480119e-8 |
GO:0032202 | telomere assembly | 5.241054e-8 |
GO:0045007 | depurination | 6.453636e-8 |
GO:0048242 | epinephrine secretion | 1.288550e-7 |
GO:0003229 | ventricular cardiac muscle tissue development | 2.045595e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.427007e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.427007e-7 |
GO:0072668 | tubulin complex biogenesis | 2.859162e-7 |
GO:0006929 | substrate-dependent cell migration | 3.571073e-7 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 4.924524e-7 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 6.833577e-7 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 7.899620e-7 |
GO:0032312 | regulation of ARF GTPase activity | 8.563663e-7 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.333689e-6 |
GO:0015874 | norepinephrine transport | 1.754924e-6 |
GO:0051788 | response to misfolded protein | 1.859767e-6 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 2.222834e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 2.316032e-6 |
GO:0051973 | positive regulation of telomerase activity | 2.544425e-6 |
GO:0006285 | base-excision repair, AP site formation | 2.572040e-6 |
GO:0090207 | regulation of triglyceride metabolic process | 2.709554e-6 |
GO:0050779 | RNA destabilization | 3.263334e-6 |
GO:0043585 | nose morphogenesis | 4.587680e-6 |
GO:0051972 | regulation of telomerase activity | 4.786325e-6 |
GO:0019388 | galactose catabolic process | 4.875799e-6 |
GO:0045006 | DNA deamination | 7.073072e-6 |
GO:0060251 | regulation of glial cell proliferation | 7.157574e-6 |
GO:0032462 | regulation of protein homooligomerization | 7.537737e-6 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 7.747410e-6 |
GO:0001757 | somite specification | 9.546684e-6 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.137465e-5 |
GO:0045217 | cell-cell junction maintenance | 1.137465e-5 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 1.139649e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.264461e-5 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.268604e-5 |
GO:0070307 | lens fiber cell development | 1.412593e-5 |
GO:0060020 | Bergmann glial cell differentiation | 1.627454e-5 |
GO:0070345 | negative regulation of fat cell proliferation | 1.658073e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 1.673976e-5 |
GO:0006544 | glycine metabolic process | 1.693361e-5 |
GO:0015816 | glycine transport | 1.784639e-5 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 1.806567e-5 |
GO:0048243 | norepinephrine secretion | 1.891434e-5 |
GO:0007021 | tubulin complex assembly | 2.032841e-5 |
GO:0071956 | cellular component maintenance at cellular level | 2.121548e-5 |
GO:0019693 | ribose phosphate metabolic process | 2.121548e-5 |
GO:0051580 | regulation of neurotransmitter uptake | 2.246172e-5 |
GO:0090209 | negative regulation of triglyceride metabolic process | 2.379039e-5 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 2.423444e-5 |
GO:0061157 | mRNA destabilization | 2.502846e-5 |
GO:0032972 | regulation of muscle filament sliding speed | 2.502846e-5 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 2.502846e-5 |
GO:2000210 | positive regulation of anoikis | 2.679254e-5 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 2.721357e-5 |
GO:0006689 | ganglioside catabolic process | 3.189885e-5 |
GO:0045618 | positive regulation of keratinocyte differentiation | 3.230987e-5 |
GO:0006108 | malate metabolic process | 3.721544e-5 |
GO:0043491 | protein kinase B signaling cascade | 3.764095e-5 |
GO:0031848 | protection from non-homologous end joining at telomere | 3.808473e-5 |
GO:0060430 | lung saccule development | 3.811240e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.823430e-5 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 4.760949e-5 |
GO:0060252 | positive regulation of glial cell proliferation | 5.094368e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.427960e-5 |
GO:0043088 | regulation of Cdc42 GTPase activity | 6.648603e-5 |
GO:0015862 | uridine transport | 6.787233e-5 |
GO:0070383 | DNA cytosine deamination | 7.648610e-5 |
GO:0055075 | potassium ion homeostasis | 7.958131e-5 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 9.411541e-5 |
GO:0030037 | actin filament reorganization involved in cell cycle | 1.196946e-4 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 1.199846e-4 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.500858e-4 |
GO:2000209 | regulation of anoikis | 1.519327e-4 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.578048e-4 |
GO:0060038 | cardiac muscle cell proliferation | 1.597623e-4 |
GO:0010866 | regulation of triglyceride biosynthetic process | 1.655249e-4 |
GO:0032463 | negative regulation of protein homooligomerization | 1.664983e-4 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 1.722722e-4 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.749452e-4 |
GO:0032203 | telomere formation via telomerase | 1.749452e-4 |
GO:0061205 | paramesonephric duct development | 1.863472e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.928016e-4 |
GO:0072089 | stem cell proliferation | 1.992239e-4 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 2.010654e-4 |
GO:0010529 | negative regulation of transposition | 2.108259e-4 |
GO:0016052 | carbohydrate catabolic process | 2.128358e-4 |
GO:0006014 | D-ribose metabolic process | 2.144514e-4 |
GO:0002071 | glandular epithelial cell maturation | 2.189755e-4 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 2.208646e-4 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 2.265046e-4 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 2.432898e-4 |
GO:0006476 | protein deacetylation | 2.619422e-4 |
GO:0006284 | base-excision repair | 2.670213e-4 |
GO:0030149 | sphingolipid catabolic process | 2.695557e-4 |
GO:0006884 | cell volume homeostasis | 2.995001e-4 |
GO:0051532 | regulation of NFAT protein import into nucleus | 3.009442e-4 |
GO:0090303 | positive regulation of wound healing | 3.022039e-4 |
GO:0035470 | positive regulation of vascular wound healing | 3.041869e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 3.041869e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 3.041869e-4 |
GO:0046890 | regulation of lipid biosynthetic process | 3.117222e-4 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 3.118391e-4 |
GO:0002357 | defense response to tumor cell | 3.316478e-4 |
GO:0014037 | Schwann cell differentiation | 3.385952e-4 |
GO:0046210 | nitric oxide catabolic process | 3.538984e-4 |
GO:0090346 | cellular organofluorine metabolic process | 3.538984e-4 |
GO:0043602 | nitrate catabolic process | 3.538984e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 3.538984e-4 |
GO:0002522 | leukocyte migration involved in immune response | 3.538984e-4 |
GO:0032793 | positive regulation of CREB transcription factor activity | 3.568746e-4 |
GO:0048627 | myoblast development | 3.798284e-4 |
GO:0007296 | vitellogenesis | 4.078960e-4 |
GO:0050685 | positive regulation of mRNA processing | 4.097065e-4 |
GO:0051496 | positive regulation of stress fiber assembly | 4.473955e-4 |
GO:0018208 | peptidyl-proline modification | 4.493349e-4 |
GO:0046466 | membrane lipid catabolic process | 4.515288e-4 |
GO:0071732 | cellular response to nitric oxide | 4.611698e-4 |
GO:0045918 | negative regulation of cytolysis | 4.643164e-4 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 4.715972e-4 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 4.715972e-4 |
GO:0009262 | deoxyribonucleotide metabolic process | 4.743224e-4 |
GO:0035601 | protein deacylation | 4.751700e-4 |
GO:0014807 | regulation of somitogenesis | 4.920323e-4 |
GO:0031330 | negative regulation of cellular catabolic process | 4.921854e-4 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 4.924032e-4 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 4.924032e-4 |
GO:0005978 | glycogen biosynthetic process | 5.013177e-4 |
GO:0018205 | peptidyl-lysine modification | 5.016399e-4 |
GO:0071300 | cellular response to retinoic acid | 5.108519e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 5.162869e-4 |
GO:0072109 | glomerular mesangium development | 5.168663e-4 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 5.238854e-4 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 5.238854e-4 |
GO:0006479 | protein methylation | 5.313727e-4 |
GO:0046687 | response to chromate | 5.339851e-4 |
GO:0033986 | response to methanol | 5.339851e-4 |
GO:0015809 | arginine transport | 5.489767e-4 |
GO:0002309 | T cell proliferation involved in immune response | 5.705684e-4 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 5.705684e-4 |
GO:0019321 | pentose metabolic process | 5.802210e-4 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 5.823745e-4 |
GO:0001830 | trophectodermal cell fate commitment | 5.823745e-4 |
GO:0006098 | pentose-phosphate shunt | 5.879328e-4 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 6.007153e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 6.026132e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 6.028195e-4 |
GO:0019318 | hexose metabolic process | 6.116454e-4 |
GO:0090150 | establishment of protein localization in membrane | 6.262989e-4 |
GO:0060419 | heart growth | 6.312503e-4 |
GO:0006386 | termination of RNA polymerase III transcription | 6.405376e-4 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 6.405376e-4 |
GO:0007512 | adult heart development | 6.507983e-4 |
GO:0035767 | endothelial cell chemotaxis | 6.593727e-4 |
GO:0016571 | histone methylation | 6.628179e-4 |
GO:0000413 | protein peptidyl-prolyl isomerization | 6.722114e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 6.730319e-4 |
GO:0045342 | MHC class II biosynthetic process | 6.799632e-4 |
GO:0043091 | L-arginine import | 6.799632e-4 |
GO:0070839 | divalent metal ion export | 6.799632e-4 |
GO:0006876 | cellular cadmium ion homeostasis | 6.799632e-4 |
GO:0015707 | nitrite transport | 6.799632e-4 |
GO:0032632 | interleukin-3 production | 6.799632e-4 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 6.862529e-4 |
GO:0046655 | folic acid metabolic process | 7.089927e-4 |
GO:0015804 | neutral amino acid transport | 7.266130e-4 |
GO:0035854 | eosinophil fate commitment | 7.650654e-4 |
GO:0030222 | eosinophil differentiation | 7.650654e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 7.671420e-4 |
GO:0044356 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine | 7.769282e-4 |
GO:0018277 | protein deamination | 7.769282e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 7.769282e-4 |
GO:0014044 | Schwann cell development | 8.037223e-4 |
GO:0006984 | ER-nucleus signaling pathway | 8.177153e-4 |
GO:0046519 | sphingoid metabolic process | 9.210539e-4 |
GO:0002067 | glandular epithelial cell differentiation | 9.296357e-4 |
GO:0050772 | positive regulation of axonogenesis | 9.368464e-4 |
GO:0032856 | activation of Ras GTPase activity | 9.395766e-4 |
GO:0015864 | pyrimidine nucleoside transport | 9.425840e-4 |
GO:0090205 | positive regulation of cholesterol metabolic process | 9.458972e-4 |
GO:0030035 | microspike assembly | 9.517635e-4 |
GO:0070574 | cadmium ion transmembrane transport | 9.580267e-4 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 9.695661e-4 |
GO:0071421 | manganese ion transmembrane transport | 9.857018e-4 |
GO:0010954 | positive regulation of protein processing | 1.010367e-3 |
GO:0071585 | detoxification of cadmium ion | 1.017391e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.026192e-3 |
GO:0003416 | endochondral bone growth | 1.029077e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 1.093204e-3 |
GO:0055017 | cardiac muscle tissue growth | 1.106914e-3 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.122709e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 1.162194e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.168049e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 1.193628e-3 |
GO:0034767 | positive regulation of ion transmembrane transport | 1.213476e-3 |
GO:0046847 | filopodium assembly | 1.232176e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 1.263391e-3 |
GO:0006400 | tRNA modification | 1.272885e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.278106e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 1.278106e-3 |
GO:0060014 | granulosa cell differentiation | 1.281154e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 1.281154e-3 |
GO:0072144 | glomerular mesangial cell development | 1.294310e-3 |
GO:0072011 | glomerular endothelium development | 1.294310e-3 |
GO:0006353 | transcription termination, DNA-dependent | 1.320213e-3 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 1.329921e-3 |
GO:0034651 | cortisol biosynthetic process | 1.330723e-3 |
GO:0035865 | cellular response to potassium ion | 1.330723e-3 |
GO:0032342 | aldosterone biosynthetic process | 1.330723e-3 |
GO:0014895 | smooth muscle hypertrophy | 1.330723e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 1.330723e-3 |
GO:0060385 | axonogenesis involved in innervation | 1.331546e-3 |
GO:0055099 | response to high density lipoprotein particle stimulus | 1.351088e-3 |
GO:0016233 | telomere capping | 1.359346e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.391623e-3 |
GO:0006672 | ceramide metabolic process | 1.426676e-3 |
GO:0006337 | nucleosome disassembly | 1.468116e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 1.496475e-3 |
GO:0014888 | striated muscle adaptation | 1.536584e-3 |
GO:0014829 | vascular smooth muscle contraction | 1.538583e-3 |
GO:0000185 | activation of MAPKKK activity | 1.539392e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.541147e-3 |
GO:0071276 | cellular response to cadmium ion | 1.557966e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.558152e-3 |
GO:0032717 | negative regulation of interleukin-8 production | 1.576511e-3 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.582345e-3 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 1.597493e-3 |
GO:0045109 | intermediate filament organization | 1.620084e-3 |
GO:0021526 | medial motor column neuron differentiation | 1.649408e-3 |
GO:0035329 | hippo signaling cascade | 1.682585e-3 |
GO:0019060 | intracellular transport of viral proteins in host cell | 1.710071e-3 |
GO:0034014 | response to triglyceride | 1.735367e-3 |
GO:0006927 | transformed cell apoptosis | 1.735367e-3 |
GO:0043171 | peptide catabolic process | 1.737019e-3 |
GO:0010610 | regulation of mRNA stability involved in response to stress | 1.767216e-3 |
GO:0010756 | positive regulation of plasminogen activation | 1.767216e-3 |
GO:0034465 | response to carbon monoxide | 1.781181e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 1.783076e-3 |
GO:0008334 | histone mRNA metabolic process | 1.795250e-3 |
GO:0034969 | histone arginine methylation | 1.834227e-3 |
GO:0033326 | cerebrospinal fluid secretion | 1.836248e-3 |
GO:0033133 | positive regulation of glucokinase activity | 1.836248e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.842371e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 1.859766e-3 |
GO:0002432 | granuloma formation | 1.859766e-3 |
GO:0015742 | alpha-ketoglutarate transport | 1.859766e-3 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 1.859766e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.859766e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 1.864094e-3 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 1.882138e-3 |
GO:0071392 | cellular response to estradiol stimulus | 1.947941e-3 |
GO:0042149 | cellular response to glucose starvation | 1.948333e-3 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.973740e-3 |
GO:0046724 | oxalic acid secretion | 1.984083e-3 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 1.984083e-3 |
GO:0034968 | histone lysine methylation | 1.996041e-3 |
GO:0032780 | negative regulation of ATPase activity | 2.024420e-3 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 2.067066e-3 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 2.067066e-3 |
GO:0051586 | positive regulation of dopamine uptake | 2.069183e-3 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 2.069183e-3 |
GO:0008624 | induction of apoptosis by extracellular signals | 2.138469e-3 |
GO:0060337 | type I interferon-mediated signaling pathway | 2.139867e-3 |
GO:0045351 | type I interferon biosynthetic process | 2.145654e-3 |
GO:0001578 | microtubule bundle formation | 2.158936e-3 |
GO:0009744 | response to sucrose stimulus | 2.222941e-3 |
GO:0071044 | histone mRNA catabolic process | 2.232865e-3 |
GO:0015858 | nucleoside transport | 2.246607e-3 |
GO:0033131 | regulation of glucokinase activity | 2.288035e-3 |
GO:0072060 | outer medullary collecting duct development | 2.344519e-3 |
GO:0072061 | inner medullary collecting duct development | 2.344519e-3 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 2.344519e-3 |
GO:0051299 | centrosome separation | 2.344519e-3 |
GO:0009637 | response to blue light | 2.344519e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 2.344519e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 2.353803e-3 |
GO:0043313 | regulation of neutrophil degranulation | 2.362592e-3 |
GO:0071584 | negative regulation of zinc ion import | 2.410639e-3 |
GO:0090281 | negative regulation of calcium ion import | 2.410639e-3 |
GO:0071279 | cellular response to cobalt ion | 2.410639e-3 |
GO:0035803 | egg coat formation | 2.410639e-3 |
GO:0006203 | dGTP catabolic process | 2.410639e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 2.410639e-3 |
GO:0031102 | neuron projection regeneration | 2.467377e-3 |
GO:0043985 | histone H4-R3 methylation | 2.499486e-3 |
GO:0065001 | specification of axis polarity | 2.499486e-3 |
GO:0051764 | actin crosslink formation | 2.572509e-3 |
GO:0001955 | blood vessel maturation | 2.583195e-3 |
GO:0006012 | galactose metabolic process | 2.586943e-3 |
GO:0017004 | cytochrome complex assembly | 2.601127e-3 |
GO:0003406 | retinal pigment epithelium development | 2.601127e-3 |
GO:0032855 | positive regulation of Rac GTPase activity | 2.628804e-3 |
GO:0071299 | cellular response to vitamin A | 2.631531e-3 |
GO:0032387 | negative regulation of intracellular transport | 2.631672e-3 |
GO:0032200 | telomere organization | 2.642195e-3 |
GO:0022616 | DNA strand elongation | 2.657874e-3 |
GO:0035265 | organ growth | 2.707812e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 2.738709e-3 |
GO:0043462 | regulation of ATPase activity | 2.748639e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 2.753680e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.758462e-3 |
GO:0000154 | rRNA modification | 2.775312e-3 |
GO:0019320 | hexose catabolic process | 2.853863e-3 |
GO:0008628 | induction of apoptosis by hormones | 2.868792e-3 |
GO:0071218 | cellular response to misfolded protein | 2.878269e-3 |
GO:0032606 | type I interferon production | 2.878269e-3 |
GO:0033002 | muscle cell proliferation | 2.897477e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 2.912399e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.984821e-3 |
GO:0090136 | epithelial cell-cell adhesion | 3.013363e-3 |
GO:0034959 | endothelin maturation | 3.015984e-3 |
GO:0010816 | calcitonin catabolic process | 3.015984e-3 |
GO:0010814 | substance P catabolic process | 3.015984e-3 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 3.037189e-3 |
GO:0001928 | regulation of exocyst assembly | 3.050161e-3 |
GO:0060178 | regulation of exocyst localization | 3.050161e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 3.070088e-3 |
GO:0034436 | glycoprotein transport | 3.094872e-3 |
GO:0009720 | detection of hormone stimulus | 3.094872e-3 |
GO:0072659 | protein localization in plasma membrane | 3.159282e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.187383e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 3.205689e-3 |
GO:0065002 | intracellular protein transmembrane transport | 3.213603e-3 |
GO:0034340 | response to type I interferon | 3.233064e-3 |
GO:0006680 | glucosylceramide catabolic process | 3.282817e-3 |
GO:0070194 | synaptonemal complex disassembly | 3.385338e-3 |
GO:0046174 | polyol catabolic process | 3.385338e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 3.385338e-3 |
GO:0018125 | peptidyl-cysteine methylation | 3.463381e-3 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 3.463381e-3 |
GO:0033189 | response to vitamin A | 3.473493e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 3.506033e-3 |
GO:0033504 | floor plate development | 3.555089e-3 |
GO:0032025 | response to cobalt ion | 3.555089e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 3.555089e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 3.642188e-3 |
GO:0022009 | central nervous system vasculogenesis | 3.727447e-3 |
GO:0043534 | blood vessel endothelial cell migration | 3.732610e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 3.736717e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 3.825153e-3 |
GO:0014002 | astrocyte development | 3.831073e-3 |
GO:0090239 | regulation of histone H4 acetylation | 3.866909e-3 |
GO:0032506 | cytokinetic process | 3.866909e-3 |
GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis | 3.877536e-3 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 3.915101e-3 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 3.921297e-3 |
GO:0032530 | regulation of microvillus organization | 3.939209e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 3.939209e-3 |
GO:0006562 | proline catabolic process | 3.957099e-3 |
GO:0021562 | vestibulocochlear nerve development | 3.968357e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 3.970213e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 3.973105e-3 |
GO:0090241 | negative regulation of histone H4 acetylation | 3.973105e-3 |
GO:0031297 | replication fork processing | 4.008222e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 4.109146e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.181824e-3 |
GO:0061013 | regulation of mRNA catabolic process | 4.279589e-3 |
GO:0048793 | pronephros development | 4.302525e-3 |
GO:0030704 | vitelline membrane formation | 4.342153e-3 |
GO:0009098 | leucine biosynthetic process | 4.342153e-3 |
GO:0006550 | isoleucine catabolic process | 4.342153e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 4.351389e-3 |
GO:0002904 | positive regulation of B cell apoptosis | 4.352071e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 4.507233e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 4.533997e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 4.533997e-3 |
GO:0002074 | extraocular skeletal muscle development | 4.533997e-3 |
GO:0071529 | cementum mineralization | 4.533997e-3 |
GO:0010940 | positive regulation of necrotic cell death | 4.576690e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 4.593641e-3 |
GO:0046390 | ribose phosphate biosynthetic process | 4.614213e-3 |
GO:0032534 | regulation of microvillus assembly | 4.614213e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 4.629490e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 4.641029e-3 |
GO:0022011 | myelination in peripheral nervous system | 4.648299e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 4.654141e-3 |
GO:0009069 | serine family amino acid metabolic process | 4.662014e-3 |
GO:0016570 | histone modification | 4.714246e-3 |
GO:0032526 | response to retinoic acid | 4.717691e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 4.836156e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 4.852977e-3 |
GO:0006734 | NADH metabolic process | 4.928729e-3 |
GO:0071474 | cellular hyperosmotic response | 4.965425e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 4.966021e-3 |
GO:0043647 | inositol phosphate metabolic process | 4.984499e-3 |
GO:0015709 | thiosulfate transport | 5.003660e-3 |
GO:0071423 | malate transmembrane transport | 5.003660e-3 |
GO:0006559 | L-phenylalanine catabolic process | 5.033040e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 5.151734e-3 |
GO:0015870 | acetylcholine transport | 5.160938e-3 |
GO:0070947 | neutrophil mediated killing of fungus | 5.165542e-3 |
GO:0070286 | axonemal dynein complex assembly | 5.165542e-3 |
GO:0061144 | alveolar secondary septum development | 5.226962e-3 |
GO:2000491 | positive regulation of hepatic stellate cell activation | 5.226962e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 5.226962e-3 |
GO:0002418 | immune response to tumor cell | 5.226962e-3 |
GO:0033505 | floor plate morphogenesis | 5.237977e-3 |
GO:0043501 | skeletal muscle adaptation | 5.262695e-3 |
GO:0007009 | plasma membrane organization | 5.361849e-3 |
GO:0046513 | ceramide biosynthetic process | 5.552962e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 5.598482e-3 |
GO:0060754 | positive regulation of mast cell chemotaxis | 5.717459e-3 |
GO:0032836 | glomerular basement membrane development | 5.717459e-3 |
GO:0006665 | sphingolipid metabolic process | 5.717633e-3 |
GO:0006059 | hexitol metabolic process | 5.845407e-3 |
GO:0046364 | monosaccharide biosynthetic process | 5.991909e-3 |
GO:0009313 | oligosaccharide catabolic process | 6.022038e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 6.040462e-3 |
GO:0035306 | positive regulation of dephosphorylation | 6.040462e-3 |
GO:0046434 | organophosphate catabolic process | 6.058973e-3 |
GO:0010939 | regulation of necrotic cell death | 6.079529e-3 |
GO:0035304 | regulation of protein dephosphorylation | 6.128197e-3 |
GO:0032525 | somite rostral/caudal axis specification | 6.180649e-3 |
GO:0021523 | somatic motor neuron differentiation | 6.196140e-3 |
GO:0006740 | NADPH regeneration | 6.204967e-3 |
GO:0030237 | female sex determination | 6.278008e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 6.311423e-3 |
GO:0018993 | somatic sex determination | 6.341331e-3 |
GO:0051492 | regulation of stress fiber assembly | 6.413949e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 6.421248e-3 |
GO:0015879 | carnitine transport | 6.541377e-3 |
GO:0042758 | long-chain fatty acid catabolic process | 6.575989e-3 |
GO:0042413 | carnitine catabolic process | 6.575989e-3 |
GO:0006273 | lagging strand elongation | 6.575989e-3 |
GO:0009992 | cellular water homeostasis | 6.590304e-3 |
GO:0007379 | segment specification | 6.602133e-3 |
GO:0016575 | histone deacetylation | 6.660891e-3 |
GO:0046365 | monosaccharide catabolic process | 6.681987e-3 |
GO:0071731 | response to nitric oxide | 6.726693e-3 |
GO:0031064 | negative regulation of histone deacetylation | 6.956930e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 6.956930e-3 |
GO:0035967 | cellular response to topologically incorrect protein | 7.041332e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 7.229045e-3 |
GO:0009226 | nucleotide-sugar biosynthetic process | 7.261954e-3 |
GO:0060263 | regulation of respiratory burst | 7.275863e-3 |
GO:0006546 | glycine catabolic process | 7.319914e-3 |
GO:0060972 | left/right pattern formation | 7.319914e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 7.319914e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 7.324860e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 7.324860e-3 |
GO:0061360 | optic chiasma development | 7.328264e-3 |
GO:0035799 | ureter maturation | 7.328264e-3 |
GO:2000597 | positive regulation of optic nerve formation | 7.328264e-3 |
GO:0021650 | vestibulocochlear nerve formation | 7.328264e-3 |
GO:0021633 | optic nerve structural organization | 7.328264e-3 |
GO:0014034 | neural crest cell fate commitment | 7.385074e-3 |
GO:0019048 | virus-host interaction | 7.553003e-3 |
GO:0072044 | collecting duct development | 7.663622e-3 |
GO:0006930 | substrate-dependent cell migration, cell extension | 7.669992e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 7.775422e-3 |
GO:0035364 | thymine transport | 7.775422e-3 |
GO:0035344 | hypoxanthine transport | 7.775422e-3 |
GO:0015854 | guanine transport | 7.775422e-3 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 7.775422e-3 |
GO:0032459 | regulation of protein oligomerization | 7.883320e-3 |
GO:0001300 | chronological cell aging | 7.970006e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 7.995939e-3 |
GO:0030213 | hyaluronan biosynthetic process | 8.055798e-3 |
GO:0090181 | regulation of cholesterol metabolic process | 8.097874e-3 |
GO:0010832 | negative regulation of myotube differentiation | 8.153784e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 8.197223e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 8.282885e-3 |
GO:0006264 | mitochondrial DNA replication | 8.511242e-3 |
GO:0015893 | drug transport | 8.527994e-3 |
GO:0021678 | third ventricle development | 8.547221e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 8.567963e-3 |
GO:0008156 | negative regulation of DNA replication | 8.649155e-3 |
GO:0061301 | cerebellum vasculature morphogenesis | 8.652768e-3 |
GO:0046951 | ketone body biosynthetic process | 8.655333e-3 |
GO:0070079 | histone H4-R3 demethylation | 8.674750e-3 |
GO:0070078 | histone H3-R2 demethylation | 8.674750e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 8.674750e-3 |
GO:0061143 | alveolar primary septum development | 8.674750e-3 |
GO:0003383 | apical constriction | 8.674750e-3 |
GO:0072086 | specification of loop of Henle identity | 8.681708e-3 |
GO:0061302 | smooth muscle cell-matrix adhesion | 8.885198e-3 |
GO:0051937 | catecholamine transport | 8.939841e-3 |
GO:0046950 | cellular ketone body metabolic process | 8.986282e-3 |
GO:0019322 | pentose biosynthetic process | 8.994734e-3 |
GO:0006268 | DNA unwinding involved in replication | 8.994734e-3 |
GO:0000917 | barrier septum formation | 9.037234e-3 |
GO:0032218 | riboflavin transport | 9.037234e-3 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 9.037234e-3 |
GO:0006499 | N-terminal protein myristoylation | 9.037234e-3 |
GO:0003264 | regulation of cardioblast proliferation | 9.054741e-3 |
GO:0070141 | response to UV-A | 9.237421e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 9.296299e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 9.359197e-3 |
GO:0070314 | G1 to G0 transition | 9.500102e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 9.500102e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033239 | negative regulation of cellular amine metabolic process | 4.303882e-8 |
GO:0002268 | follicular dendritic cell differentiation | 4.919309e-8 |
GO:0009082 | branched chain family amino acid biosynthetic process | 4.972615e-8 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.201569e-7 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.589239e-7 |
GO:0021681 | cerebellar granular layer development | 4.163677e-7 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.205991e-7 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.228154e-6 |
GO:0030865 | cortical cytoskeleton organization | 1.574995e-6 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 2.236262e-6 |
GO:0009912 | auditory receptor cell fate commitment | 3.466724e-6 |
GO:0006342 | chromatin silencing | 3.877583e-6 |
GO:0045814 | negative regulation of gene expression, epigenetic | 4.192140e-6 |
GO:0032479 | regulation of type I interferon production | 6.594253e-6 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 7.788595e-6 |
GO:0032375 | negative regulation of cholesterol transport | 7.868154e-6 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 9.785290e-6 |
GO:0030866 | cortical actin cytoskeleton organization | 1.003500e-5 |
GO:0032481 | positive regulation of type I interferon production | 1.320447e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 1.386323e-5 |
GO:0050995 | negative regulation of lipid catabolic process | 1.775469e-5 |
GO:0010388 | cullin deneddylation | 1.809123e-5 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.335103e-5 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 2.502777e-5 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 2.665386e-5 |
GO:0021707 | cerebellar granule cell differentiation | 3.506212e-5 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 3.743816e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 4.591411e-5 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 4.685215e-5 |
GO:0021683 | cerebellar granular layer morphogenesis | 4.794083e-5 |
GO:0032922 | circadian regulation of gene expression | 5.003219e-5 |
GO:0010288 | response to lead ion | 5.383565e-5 |
GO:0043985 | histone H4-R3 methylation | 6.487961e-5 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 6.487961e-5 |
GO:0006476 | protein deacetylation | 7.503516e-5 |
GO:0010984 | regulation of lipoprotein particle clearance | 8.265930e-5 |
GO:0051583 | dopamine uptake | 9.011000e-5 |
GO:0032099 | negative regulation of appetite | 9.498864e-5 |
GO:0035601 | protein deacylation | 1.185306e-4 |
GO:0032776 | DNA methylation on cytosine | 1.220780e-4 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.224008e-4 |
GO:0010887 | negative regulation of cholesterol storage | 1.224175e-4 |
GO:0072593 | reactive oxygen species metabolic process | 1.750731e-4 |
GO:2000974 | negative regulation of pro-B cell differentiation | 1.804324e-4 |
GO:0032096 | negative regulation of response to food | 1.804324e-4 |
GO:0019048 | virus-host interaction | 1.921257e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.928930e-4 |
GO:0032648 | regulation of interferon-beta production | 2.001332e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 2.027894e-4 |
GO:0050685 | positive regulation of mRNA processing | 2.060784e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 2.087767e-4 |
GO:0070141 | response to UV-A | 2.156064e-4 |
GO:0043949 | regulation of cAMP-mediated signaling | 2.349456e-4 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 2.809622e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.071103e-4 |
GO:0034382 | chylomicron remnant clearance | 3.071103e-4 |
GO:0021526 | medial motor column neuron differentiation | 3.605396e-4 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 3.605396e-4 |
GO:0031507 | heterochromatin formation | 3.684531e-4 |
GO:0000387 | spliceosomal snRNP assembly | 4.024582e-4 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 4.154723e-4 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 4.154723e-4 |
GO:0018023 | peptidyl-lysine trimethylation | 4.423886e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 4.553760e-4 |
GO:2000774 | positive regulation of cellular senescence | 4.929202e-4 |
GO:0090402 | oncogene-induced senescence | 4.929202e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 4.929202e-4 |
GO:0070078 | histone H3-R2 demethylation | 5.270460e-4 |
GO:0070079 | histone H4-R3 demethylation | 5.270460e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 5.270460e-4 |
GO:0014909 | smooth muscle cell migration | 5.293195e-4 |
GO:0008334 | histone mRNA metabolic process | 5.503032e-4 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 5.601145e-4 |
GO:0061013 | regulation of mRNA catabolic process | 5.782183e-4 |
GO:0035095 | behavioral response to nicotine | 5.903418e-4 |
GO:0019344 | cysteine biosynthetic process | 5.903418e-4 |
GO:0007000 | nucleolus organization | 5.903418e-4 |
GO:0010822 | positive regulation of mitochondrion organization | 6.008927e-4 |
GO:0000072 | M phase specific microtubule process | 6.277836e-4 |
GO:0033119 | negative regulation of RNA splicing | 6.406766e-4 |
GO:0032020 | ISG15-protein conjugation | 6.453402e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 6.506172e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 6.528857e-4 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 7.317247e-4 |
GO:0016575 | histone deacetylation | 7.354735e-4 |
GO:0043525 | positive regulation of neuron apoptosis | 8.281288e-4 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 8.534000e-4 |
GO:0034637 | cellular carbohydrate biosynthetic process | 8.635989e-4 |
GO:2000210 | positive regulation of anoikis | 9.486503e-4 |
GO:0090140 | regulation of mitochondrial fission | 9.596332e-4 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 9.596332e-4 |
GO:0090116 | C-5 methylation of cytosine | 9.736278e-4 |
GO:0030325 | adrenal gland development | 9.746428e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 9.860168e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 9.886574e-4 |
GO:0048570 | notochord morphogenesis | 1.088748e-3 |
GO:0042743 | hydrogen peroxide metabolic process | 1.097462e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 1.128847e-3 |
GO:0030421 | defecation | 1.128847e-3 |
GO:0070925 | organelle assembly | 1.192240e-3 |
GO:0071593 | lymphocyte aggregation | 1.203693e-3 |
GO:0035435 | phosphate ion transmembrane transport | 1.203693e-3 |
GO:0032536 | regulation of cell projection size | 1.203931e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 1.239939e-3 |
GO:0010721 | negative regulation of cell development | 1.241893e-3 |
GO:0045948 | positive regulation of translational initiation | 1.301500e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 1.319696e-3 |
GO:0072144 | glomerular mesangial cell development | 1.335569e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.335569e-3 |
GO:0002051 | osteoblast fate commitment | 1.351298e-3 |
GO:0090169 | regulation of spindle assembly | 1.367815e-3 |
GO:0090234 | regulation of kinetochore assembly | 1.367815e-3 |
GO:0006344 | maintenance of chromatin silencing | 1.405950e-3 |
GO:0048663 | neuron fate commitment | 1.417123e-3 |
GO:0009411 | response to UV | 1.486452e-3 |
GO:0031133 | regulation of axon diameter | 1.498386e-3 |
GO:0006749 | glutathione metabolic process | 1.519197e-3 |
GO:0032108 | negative regulation of response to nutrient levels | 1.589092e-3 |
GO:0072044 | collecting duct development | 1.604118e-3 |
GO:0045806 | negative regulation of endocytosis | 1.609121e-3 |
GO:0046847 | filopodium assembly | 1.618036e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 1.622222e-3 |
GO:2000772 | regulation of cellular senescence | 1.626306e-3 |
GO:0043654 | recognition of apoptotic cell | 1.653506e-3 |
GO:0043276 | anoikis | 1.683892e-3 |
GO:0007386 | compartment pattern specification | 1.683892e-3 |
GO:0042552 | myelination | 1.701281e-3 |
GO:0032095 | regulation of response to food | 1.768987e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 1.793584e-3 |
GO:0048148 | behavioral response to cocaine | 1.817278e-3 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 1.968320e-3 |
GO:0051586 | positive regulation of dopamine uptake | 1.968320e-3 |
GO:0014719 | satellite cell activation | 1.968320e-3 |
GO:0015732 | prostaglandin transport | 1.986375e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 2.014607e-3 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 2.177678e-3 |
GO:0010821 | regulation of mitochondrion organization | 2.241223e-3 |
GO:0032728 | positive regulation of interferon-beta production | 2.253517e-3 |
GO:0071218 | cellular response to misfolded protein | 2.258192e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 2.258192e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 2.298229e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 2.298229e-3 |
GO:0051835 | positive regulation of synapse structural plasticity | 2.298229e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 2.298229e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 2.612328e-3 |
GO:0048627 | myoblast development | 2.727892e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 2.727892e-3 |
GO:0022601 | menstrual cycle phase | 2.807251e-3 |
GO:0046329 | negative regulation of JNK cascade | 2.810016e-3 |
GO:0003032 | detection of oxygen | 2.823577e-3 |
GO:0051865 | protein autoubiquitination | 2.842935e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 3.030201e-3 |
GO:0048710 | regulation of astrocyte differentiation | 3.049061e-3 |
GO:0006997 | nucleus organization | 3.097094e-3 |
GO:0005978 | glycogen biosynthetic process | 3.115495e-3 |
GO:0051823 | regulation of synapse structural plasticity | 3.160891e-3 |
GO:0015780 | nucleotide-sugar transport | 3.160891e-3 |
GO:0006783 | heme biosynthetic process | 3.186223e-3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.197753e-3 |
GO:0006467 | protein thiol-disulfide exchange | 3.383382e-3 |
GO:0051026 | chiasma assembly | 3.405777e-3 |
GO:0060167 | regulation of adenosine receptor signaling pathway | 3.445545e-3 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 3.478809e-3 |
GO:2000647 | negative regulation of stem cell proliferation | 3.478809e-3 |
GO:0046108 | uridine metabolic process | 3.478809e-3 |
GO:0010839 | negative regulation of keratinocyte proliferation | 3.478809e-3 |
GO:0035921 | desmosome disassembly | 3.478809e-3 |
GO:0046373 | L-arabinose metabolic process | 3.480051e-3 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 3.480051e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 3.495006e-3 |
GO:0007418 | ventral midline development | 3.495006e-3 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 3.495006e-3 |
GO:0022038 | corpus callosum development | 3.727961e-3 |
GO:0009069 | serine family amino acid metabolic process | 3.782192e-3 |
GO:0010869 | regulation of receptor biosynthetic process | 3.791573e-3 |
GO:0046128 | purine ribonucleoside metabolic process | 3.833925e-3 |
GO:0042278 | purine nucleoside metabolic process | 3.849461e-3 |
GO:0006657 | CDP-choline pathway | 3.871677e-3 |
GO:0046015 | regulation of transcription by glucose | 3.871677e-3 |
GO:0072109 | glomerular mesangium development | 3.891981e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 3.891981e-3 |
GO:0008366 | axon ensheathment | 4.005352e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 4.065353e-3 |
GO:0071157 | negative regulation of cell cycle arrest | 4.159961e-3 |
GO:0032606 | type I interferon production | 4.159961e-3 |
GO:0006984 | ER-nucleus signaling pathway | 4.189102e-3 |
GO:0050768 | negative regulation of neurogenesis | 4.304953e-3 |
GO:0032465 | regulation of cytokinesis | 4.488413e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 4.561335e-3 |
GO:0007051 | spindle organization | 4.708170e-3 |
GO:0016926 | protein desumoylation | 4.732402e-3 |
GO:0032796 | uropod organization | 4.732402e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 4.797246e-3 |
GO:0016032 | viral reproduction | 4.864806e-3 |
GO:0033627 | cell adhesion mediated by integrin | 4.947202e-3 |
GO:0030035 | microspike assembly | 5.009282e-3 |
GO:0034498 | early endosome to Golgi transport | 5.158052e-3 |
GO:0010034 | response to acetate | 5.158052e-3 |
GO:0033522 | histone H2A ubiquitination | 5.244558e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 5.261334e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 5.409141e-3 |
GO:0035444 | nickel ion transmembrane transport | 5.420764e-3 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 5.420764e-3 |
GO:0006094 | gluconeogenesis | 5.761263e-3 |
GO:0006446 | regulation of translational initiation | 5.794265e-3 |
GO:0048840 | otolith development | 5.812462e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 5.812462e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 5.902432e-3 |
GO:0021877 | forebrain neuron fate commitment | 5.948452e-3 |
GO:0045606 | positive regulation of epidermal cell differentiation | 6.030401e-3 |
GO:0042668 | auditory receptor cell fate determination | 6.030401e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 6.066383e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 6.066383e-3 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 6.066383e-3 |
GO:0032927 | positive regulation of activin receptor signaling pathway | 6.066383e-3 |
GO:0000917 | barrier septum formation | 6.066383e-3 |
GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure | 6.066383e-3 |
GO:0000722 | telomere maintenance via recombination | 6.066383e-3 |
GO:0071870 | cellular response to catecholamine stimulus | 6.108877e-3 |
GO:0009141 | nucleoside triphosphate metabolic process | 6.128461e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 6.353543e-3 |
GO:0050928 | negative regulation of positive chemotaxis | 6.525565e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 6.525565e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 6.525565e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 6.525565e-3 |
GO:0032782 | bile acid secretion | 6.525565e-3 |
GO:0003096 | renal sodium ion transport | 6.525565e-3 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 6.525565e-3 |
GO:0010255 | glucose mediated signaling pathway | 6.525565e-3 |
GO:0035470 | positive regulation of vascular wound healing | 6.525565e-3 |
GO:0060674 | placenta blood vessel development | 6.551976e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 6.872696e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 6.990345e-3 |
GO:0007141 | male meiosis I | 6.990345e-3 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 7.427274e-3 |
GO:0032418 | lysosome localization | 7.427274e-3 |
GO:0014807 | regulation of somitogenesis | 7.427274e-3 |
GO:0097150 | neuronal stem cell maintenance | 7.452016e-3 |
GO:0031167 | rRNA methylation | 7.452016e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 7.464705e-3 |
GO:0006575 | cellular modified amino acid metabolic process | 7.472368e-3 |
GO:0021587 | cerebellum morphogenesis | 7.529175e-3 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 7.560304e-3 |
GO:0045110 | intermediate filament bundle assembly | 7.560304e-3 |
GO:0060168 | positive regulation of adenosine receptor signaling pathway | 7.560304e-3 |
GO:0071206 | establishment of protein localization to juxtaparanode region of axon | 7.560304e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 7.560304e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 7.560304e-3 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 7.560304e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 7.560304e-3 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 7.560304e-3 |
GO:0034421 | post-translational protein acetylation | 7.560304e-3 |
GO:0021979 | hypothalamus cell differentiation | 7.560304e-3 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 7.588195e-3 |
GO:0007044 | cell-substrate junction assembly | 7.685919e-3 |
GO:0060712 | spongiotrophoblast layer development | 7.837794e-3 |
GO:0021575 | hindbrain morphogenesis | 7.842135e-3 |
GO:0006398 | histone mRNA 3'-end processing | 7.899873e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 7.899873e-3 |
GO:0090209 | negative regulation of triglyceride metabolic process | 7.917353e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 7.962984e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 7.990789e-3 |
GO:0008643 | carbohydrate transport | 8.172890e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 8.233389e-3 |
GO:0008356 | asymmetric cell division | 8.249515e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 8.249515e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 8.254645e-3 |
GO:0043932 | ossification involved in bone remodeling | 8.260678e-3 |
GO:0015793 | glycerol transport | 8.260678e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 8.260678e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 8.260678e-3 |
GO:0006184 | GTP catabolic process | 8.317450e-3 |
GO:2000981 | negative regulation of inner ear receptor cell differentiation | 8.329435e-3 |
GO:0060192 | negative regulation of lipase activity | 8.342401e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 8.382339e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 8.405602e-3 |
GO:0060032 | notochord regression | 8.422841e-3 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 8.562790e-3 |
GO:0007131 | reciprocal meiotic recombination | 8.660198e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 8.681728e-3 |
GO:0007258 | JUN phosphorylation | 8.696966e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 9.096814e-3 |
GO:0035412 | regulation of catenin import into nucleus | 9.129495e-3 |
GO:0044030 | regulation of DNA methylation | 9.177274e-3 |
GO:0010870 | positive regulation of receptor biosynthetic process | 9.323050e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 9.323050e-3 |
GO:0045687 | positive regulation of glial cell differentiation | 9.460166e-3 |
GO:0007032 | endosome organization | 9.524366e-3 |
GO:0048711 | positive regulation of astrocyte differentiation | 9.618395e-3 |
GO:0032098 | regulation of appetite | 9.748841e-3 |
GO:0003219 | cardiac right ventricle formation | 9.751912e-3 |
GO:0043045 | DNA methylation involved in embryo development | 9.979463e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 9.979463e-3 |
GO:0018342 | protein prenylation | 9.979463e-3 |
GO:0048664 | neuron fate determination | 1.007389e-2 |
GO:0015824 | proline transport | 1.007389e-2 |
GO:0000725 | recombinational repair | 1.008398e-2 |
GO:0000060 | protein import into nucleus, translocation | 1.008923e-2 |
GO:0007143 | female meiosis | 1.017819e-2 |
GO:0009650 | UV protection | 1.019015e-2 |
GO:0032319 | regulation of Rho GTPase activity | 1.031161e-2 |
GO:0000212 | meiotic spindle organization | 1.041847e-2 |
GO:0051956 | negative regulation of amino acid transport | 1.041847e-2 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.049375e-2 |
GO:0032218 | riboflavin transport | 1.051354e-2 |
GO:0006235 | dTTP biosynthetic process | 1.051354e-2 |
GO:0072143 | mesangial cell development | 1.074764e-2 |
GO:0070584 | mitochondrion morphogenesis | 1.074764e-2 |
GO:0022411 | cellular component disassembly | 1.077575e-2 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.085330e-2 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 1.116550e-2 |
GO:0006195 | purine nucleotide catabolic process | 1.118154e-2 |
GO:0042744 | hydrogen peroxide catabolic process | 1.128048e-2 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.136819e-2 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.156624e-2 |
GO:0042420 | dopamine catabolic process | 1.161810e-2 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.161810e-2 |
GO:0006281 | DNA repair | 1.162905e-2 |
GO:0030505 | inorganic diphosphate transport | 1.172878e-2 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.190710e-2 |
GO:0055075 | potassium ion homeostasis | 1.215542e-2 |
GO:0035524 | proline transmembrane transport | 1.215542e-2 |
GO:0051220 | cytoplasmic sequestering of protein | 1.222510e-2 |
GO:0010871 | negative regulation of receptor biosynthetic process | 1.222510e-2 |
GO:0008652 | cellular amino acid biosynthetic process | 1.223328e-2 |
GO:0021682 | nerve maturation | 1.224059e-2 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 1.224059e-2 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.224059e-2 |
GO:0019047 | provirus integration | 1.224059e-2 |
GO:0045575 | basophil activation | 1.224059e-2 |
GO:0006256 | UDP catabolic process | 1.224059e-2 |
GO:0010996 | response to auditory stimulus | 1.224059e-2 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1.224059e-2 |
GO:0018344 | protein geranylgeranylation | 1.224059e-2 |
GO:0072337 | modified amino acid transport | 1.235805e-2 |
GO:0071845 | cellular component disassembly at cellular level | 1.243488e-2 |
GO:0090045 | positive regulation of deacetylase activity | 1.244211e-2 |
GO:0002077 | acrosome matrix dispersal | 1.244211e-2 |
GO:0051292 | nuclear pore complex assembly | 1.247808e-2 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.247808e-2 |
GO:0071577 | zinc ion transmembrane transport | 1.264649e-2 |
GO:0051764 | actin crosslink formation | 1.265888e-2 |
GO:2000171 | negative regulation of dendrite development | 1.291960e-2 |
GO:0006999 | nuclear pore organization | 1.297407e-2 |
GO:0042697 | menopause | 1.299925e-2 |
GO:0072076 | nephrogenic mesenchyme development | 1.299925e-2 |
GO:0072539 | T-helper 17 cell differentiation | 1.299925e-2 |
GO:0018243 | protein O-linked glycosylation via threonine | 1.299925e-2 |
GO:0032799 | low-density lipoprotein receptor particle metabolic process | 1.299925e-2 |
GO:0002155 | regulation of thyroid hormone mediated signaling pathway | 1.299925e-2 |
GO:0018242 | protein O-linked glycosylation via serine | 1.299925e-2 |
GO:0045651 | positive regulation of macrophage differentiation | 1.309520e-2 |
GO:0033590 | response to cobalamin | 1.309520e-2 |
GO:0008625 | induction of apoptosis via death domain receptors | 1.311177e-2 |
GO:0071044 | histone mRNA catabolic process | 1.317356e-2 |
GO:0006700 | C21-steroid hormone biosynthetic process | 1.336311e-2 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.347422e-2 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.359785e-2 |
GO:0043503 | skeletal muscle fiber adaptation | 1.374859e-2 |
GO:0006264 | mitochondrial DNA replication | 1.374859e-2 |
GO:0032277 | negative regulation of gonadotropin secretion | 1.431253e-2 |
GO:0001893 | maternal placenta development | 1.439958e-2 |
GO:0046039 | GTP metabolic process | 1.440687e-2 |
GO:0009071 | serine family amino acid catabolic process | 1.448444e-2 |
GO:0060669 | embryonic placenta morphogenesis | 1.450167e-2 |
GO:0072521 | purine-containing compound metabolic process | 1.450451e-2 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 1.460654e-2 |
GO:0033327 | Leydig cell differentiation | 1.462058e-2 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.472605e-2 |
GO:2000980 | regulation of inner ear receptor cell differentiation | 1.473612e-2 |
GO:0015758 | glucose transport | 1.533277e-2 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 1.540561e-2 |
GO:0051289 | protein homotetramerization | 1.553970e-2 |
GO:0021696 | cerebellar cortex morphogenesis | 1.554049e-2 |
GO:0021999 | neural plate anterior/posterior regionalization | 1.555067e-2 |
GO:0009309 | amine biosynthetic process | 1.563846e-2 |
GO:0097039 | protein linear polyubiquitination | 1.577287e-2 |
GO:0031427 | response to methotrexate | 1.577287e-2 |
GO:0045686 | negative regulation of glial cell differentiation | 1.615406e-2 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 1.622932e-2 |
GO:0014060 | regulation of epinephrine secretion | 1.622932e-2 |
GO:0048672 | positive regulation of collateral sprouting | 1.622932e-2 |
GO:0035967 | cellular response to topologically incorrect protein | 1.659654e-2 |
GO:0006778 | porphyrin-containing compound metabolic process | 1.672906e-2 |
GO:0050771 | negative regulation of axonogenesis | 1.692549e-2 |
GO:0090076 | relaxation of skeletal muscle | 1.697582e-2 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 1.697582e-2 |
GO:0022010 | central nervous system myelination | 1.702738e-2 |
GO:0030719 | P granule organization | 1.725374e-2 |
GO:0046654 | tetrahydrofolate biosynthetic process | 1.725374e-2 |
GO:0043201 | response to leucine | 1.725374e-2 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 1.725374e-2 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.725374e-2 |
GO:0045908 | negative regulation of vasodilation | 1.758741e-2 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.758741e-2 |
GO:0002230 | positive regulation of defense response to virus by host | 1.758741e-2 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.805765e-2 |
GO:0040040 | thermosensory behavior | 1.809709e-2 |
GO:0097029 | mature dendritic cell differentiation | 1.809709e-2 |
GO:0071280 | cellular response to copper ion | 1.809709e-2 |
GO:0014028 | notochord formation | 1.809709e-2 |
GO:0006550 | isoleucine catabolic process | 1.809709e-2 |
GO:0009098 | leucine biosynthetic process | 1.809709e-2 |
GO:0000045 | autophagic vacuole assembly | 1.815201e-2 |
GO:0042696 | menarche | 1.819243e-2 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.822356e-2 |
GO:0032863 | activation of Rac GTPase activity | 1.825668e-2 |
GO:0000154 | rRNA modification | 1.849532e-2 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 1.866942e-2 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 1.866942e-2 |
GO:0046415 | urate metabolic process | 1.869662e-2 |
GO:0040019 | positive regulation of embryonic development | 1.873238e-2 |
GO:0003254 | regulation of membrane depolarization | 1.896976e-2 |
GO:0071480 | cellular response to gamma radiation | 1.901605e-2 |
GO:0007183 | SMAD protein complex assembly | 1.901605e-2 |
GO:0051323 | metaphase | 1.904689e-2 |
GO:0007288 | sperm axoneme assembly | 1.904689e-2 |
GO:0006924 | activation-induced cell death of T cells | 1.937368e-2 |
GO:0031122 | cytoplasmic microtubule organization | 1.938962e-2 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.956949e-2 |
GO:0060457 | negative regulation of digestive system process | 1.986687e-2 |
GO:0070483 | detection of hypoxia | 1.986687e-2 |
GO:0031643 | positive regulation of myelination | 1.986687e-2 |
GO:0033128 | negative regulation of histone phosphorylation | 1.986687e-2 |
GO:0006434 | seryl-tRNA aminoacylation | 1.986687e-2 |
GO:0007089 | traversing start control point of mitotic cell cycle | 1.986687e-2 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.986687e-2 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.995595e-2 |
GO:0046513 | ceramide biosynthetic process | 2.000683e-2 |
GO:0032288 | myelin assembly | 2.001563e-2 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 2.001563e-2 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 2.029121e-2 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 2.029121e-2 |
GO:0021985 | neurohypophysis development | 2.029121e-2 |
GO:0018993 | somatic sex determination | 2.029121e-2 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 2.034314e-2 |
GO:0008637 | apoptotic mitochondrial changes | 2.043074e-2 |
GO:0046102 | inosine metabolic process | 2.057282e-2 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 2.057282e-2 |
GO:0030042 | actin filament depolymerization | 2.057282e-2 |
GO:0043011 | myeloid dendritic cell differentiation | 2.063522e-2 |
GO:0002238 | response to molecule of fungal origin | 2.072708e-2 |
GO:0045684 | positive regulation of epidermis development | 2.098720e-2 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 2.100548e-2 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.122180e-2 |
GO:0051693 | actin filament capping | 2.139916e-2 |
GO:0016458 | gene silencing | 2.162272e-2 |
GO:0051567 | histone H3-K9 methylation | 2.163097e-2 |
GO:0048242 | epinephrine secretion | 2.167709e-2 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.200358e-2 |
GO:2000278 | regulation of DNA biosynthetic process | 2.222978e-2 |
GO:0021759 | globus pallidus development | 2.247656e-2 |
GO:0015760 | glucose-6-phosphate transport | 2.247656e-2 |
GO:0048133 | male germ-line stem cell division | 2.266852e-2 |
GO:0043402 | glucocorticoid mediated signaling pathway | 2.266852e-2 |
GO:0007412 | axon target recognition | 2.266852e-2 |
GO:0035021 | negative regulation of Rac protein signal transduction | 2.266852e-2 |
GO:0042306 | regulation of protein import into nucleus | 2.281344e-2 |
GO:0043252 | sodium-independent organic anion transport | 2.296060e-2 |
GO:0021528 | commissural neuron differentiation in spinal cord | 2.296060e-2 |
GO:0002561 | basophil degranulation | 2.296060e-2 |
GO:0010225 | response to UV-C | 2.304414e-2 |
GO:0010761 | fibroblast migration | 2.320119e-2 |
GO:0007440 | foregut morphogenesis | 2.331898e-2 |
GO:0042755 | eating behavior | 2.340053e-2 |
GO:0072050 | S-shaped body morphogenesis | 2.340102e-2 |
GO:0072049 | comma-shaped body morphogenesis | 2.340102e-2 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 2.414305e-2 |
GO:0009154 | purine ribonucleotide catabolic process | 2.431799e-2 |
GO:0051261 | protein depolymerization | 2.468963e-2 |
GO:0045351 | type I interferon biosynthetic process | 2.468963e-2 |
GO:0007264 | small GTPase mediated signal transduction | 2.497151e-2 |
GO:0097084 | vascular smooth muscle cell development | 2.497932e-2 |
GO:0009166 | nucleotide catabolic process | 2.506153e-2 |
GO:0015862 | uridine transport | 2.513030e-2 |
GO:0070842 | aggresome assembly | 2.513030e-2 |
GO:0006493 | protein O-linked glycosylation | 2.526279e-2 |
GO:0060014 | granulosa cell differentiation | 2.538592e-2 |
GO:0042396 | phosphagen biosynthetic process | 2.538592e-2 |
GO:0000724 | double-strand break repair via homologous recombination | 2.548620e-2 |
GO:0010155 | regulation of proton transport | 2.598377e-2 |
GO:0006098 | pentose-phosphate shunt | 2.604321e-2 |
GO:0046849 | bone remodeling | 2.695991e-2 |
GO:0050779 | RNA destabilization | 2.712856e-2 |
GO:0019322 | pentose biosynthetic process | 2.712856e-2 |
GO:0072282 | metanephric nephron tubule morphogenesis | 2.716129e-2 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 2.758679e-2 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 2.764375e-2 |
GO:2000737 | negative regulation of stem cell differentiation | 2.764375e-2 |
GO:0045925 | positive regulation of female receptivity | 2.764375e-2 |
GO:0002678 | positive regulation of chronic inflammatory response | 2.805373e-2 |
GO:0045618 | positive regulation of keratinocyte differentiation | 2.814446e-2 |
GO:0032855 | positive regulation of Rac GTPase activity | 2.830370e-2 |
GO:2000209 | regulation of anoikis | 2.848506e-2 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 2.862167e-2 |
GO:0006927 | transformed cell apoptosis | 2.862167e-2 |
GO:0006290 | pyrimidine dimer repair | 2.862167e-2 |
GO:0003218 | cardiac left ventricle formation | 2.862167e-2 |
GO:0051156 | glucose 6-phosphate metabolic process | 2.863895e-2 |
GO:0015864 | pyrimidine nucleoside transport | 2.863895e-2 |